Market revenue in 2023 | USD 199.4 million |
Market revenue in 2030 | USD 473.9 million |
Growth rate | 13.2% (CAGR from 2023 to 2030) |
Largest segment | Disposable equipment |
Fastest growing segment | Disposable Equipment |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Disposable Equipment, Capital Equipment, Reusable Equipment |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Stryker Corp, Abbott Laboratories, Smith & Nephew PLC, Johnson & Johnson, AngioDynamics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiofrequency ablation devices market will help companies and investors design strategic landscapes.
Disposable equipment was the largest segment with a revenue share of 42.78% in 2023. Horizon Databook has segmented the China radiofrequency ablation devices market based on disposable equipment, capital equipment, reusable equipment covering the revenue growth of each sub-segment from 2018 to 2030.
Many studies in China demonstrate the upcoming need for utilization RFA technology as an alternative to conventional surgical treatments, boosting growth of the market. HCC is the most prevalent form of malignancy in the liver and is the fourth leading cause of cancer-related deaths.
In China, consequently accounting for more than 50% of HCC cases worldwide. Both RFA and hepatic resection are accepted as first-line of treatment for HCC in China. However, the indications for both the treatment options are distinct and do not coincide.
For instance, according to the 2017 guideline for HCC treatment, liver resection is the first-line of treatment for two to three nodules or a single tumor along with the normal liver functioning and no indication for vascular invasion/extrahepatic lesions.
Horizon Databook provides a detailed overview of country-level data and insights on the China radiofrequency ablation devices market , including forecasts for subscribers. This country databook contains high-level insights into China radiofrequency ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account